---

---

tags : Disease    symbols : Bhc   

save search

---

Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc. and more among the major companies in the market- Technavio
Published: 2023-12-01 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| Email alert Add to watchlist
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| Email alert Add to watchlist
BCLI | $0.5384 4.69% 4.48% 1M |

Health Technology

| Email alert Add to watchlist
VTRS | $11.25 1.17% 1.16% 4.7M |

Health Technology

| Email alert Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| Email alert Add to watchlist
disease companies health therapeutics market

---

Technological Advancements and Research Efforts Propel Neuromuscular Disease Therapeutics Market Growth
Published: 2023-10-27 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -11.93% | O: -18.18% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -1.63% | O: -3.68% H: 0.0% C: 0.0%
VTRS | $11.25 1.17% 1.16% 4.7M |

Health Technology

| 23.69% | O: 0.0% H: 0.17% C: -2.45%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -1.29% | O: -0.23% H: 0.08% C: -1.92%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 29.87% | O: -0.59% H: 0.15% C: -1.79%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -14.36% | O: -15.73% H: 0.0% C: 0.0%
BCLI | $0.5384 4.69% 4.48% 1M |

Health Technology

| 216.77% | O: 3.73% H: 1.8% C: -4.19%
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| -19.05% | O: -0.45% H: 0.12% C: -2.28%
propel disease research therapeutics growth market

---

Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S.
Published: 2023-10-10 (Crawled : 13:30) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 14.25% | O: 1.18% H: 1.81% C: 0.52%
liver disease report health pharmaceuticals trends

---

Global Huntington's Disease Treatment Market Analysis Report 2023-2030: Novel Approaches, Regional Trends, and Research Endeavors
Published: 2023-09-06 (Crawled : 00:00) - prnewswire.com
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 4.55% | O: -0.96% H: 1.93% C: 1.69%
SGMO | $0.5143 6.02% 5.68% 1M |

Health Technology

| -48.0% | O: 0.0% H: 3.0% C: -4.77%
NBIX M | $132.03 -0.39% -0.39% 560K |

Health Technology

| 20.93% | O: 0.44% H: 0.23% C: -1.97%
disease report treatment research global market

---

DelveInsight Evaluates a Robust Dry Eye Disease Clinical Trial Pipeline as 60+ Influential Pharma Players to Set Foot in the Domain
Published: 2023-05-23 (Crawled : 15:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 10.85% | O: -1.22% H: 0.0% C: -0.62%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -7.6% | O: 0.74% H: 0.0% C: -1.22%
GKOS M | $96.5 1.44% 0.0% 700K |

Health Technology

| 63.39% | O: -0.71% H: 2.06% C: -1.05%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -0.68% | O: -2.27% H: 4.24% C: -2.21%
ALC | $79.55 1.38% -0.25% 1.1M |

Health Technology

| -2.58% | O: -0.51% H: 0.02% C: -3.25%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 13.98% | O: -0.31% H: 0.26% C: -1.34%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -16.26% | O: -0.01% H: 0.0% C: 0.0%
OCUL | News | $5.22 -10.92% -12.26% 9.1M |

Health Technology

| 15.21% | O: 4.45% H: 7.65% C: 2.21%
GRFS | News | $6.29 -3.82% -3.97% 1.2M |

Health Technology

| -27.41% | O: 0.78% H: 0.0% C: -3.74%
ALDX | News | $3.865 -2.89% -2.98% 430K |

Health Technology

| -59.22% | O: 0.0% H: 2.36% C: 0.61%
pharma disease pipeline set eye trial

---

Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week(R) 2023
Published: 2023-05-08 (Crawled : 12:20) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 49.91% | O: 0.94% H: 2.55% C: 1.78%
disease presentation pharmaceuticals

---

Insights on the Allergic Conjunctivitis Global Market to 2031 - by Drug Class, Disease Type, Distribution Channel and Region
Published: 2023-01-05 (Crawled : 20:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 22.58% | O: 0.04% H: 0.0% C: -1.84%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 2.51% | O: 0.35% H: 1.43% C: 1.28%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -18.93% | O: 0.74% H: 0.44% C: 0.07%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 22.07% | O: 0.84% H: 4.71% C: 3.46%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 1.02% | O: 0.83% H: 1.98% C: 1.04%
drug global disease distribution market

---

SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION
Published: 2022-10-12 (Crawled : 12:20) - prnewswire.com
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 32.22% | O: -0.3% H: 2.58% C: 2.12%
pharmaceuticals liver trends disease report growing health

---

USD 45.37 Mn incremental growth expected in Darier Disease Drugs Market -- Driven by an increase in demand for advanced dermatological diagnosis
Published: 2022-09-29 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 33.95% | O: -3.32% H: 4.73% C: 4.73%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 51.07% | O: 1.87% H: 0.0% C: 0.0%
VTRS | $11.25 1.17% 1.16% 4.7M |

Health Technology

| 27.38% | O: -1.26% H: 0.7% C: -0.23%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 21.96% | O: 0.17% H: 1.1% C: 0.16%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 34.42% | O: -0.14% H: 0.53% C: -0.2%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 17.0% | O: -1.2% H: 0.0% C: -5.83%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 14.22% | O: 0.17% H: 0.28% C: -1.47%
disease expected dermatological growth market

---

8 MM Ulcerative Colitis Market Forecasts, Epidemiology & Pipeline Analysis 2022-2027: Novel Emerging Drugs will Shift the Inflammatory Bowel Disease (IBD) Treatment Paradigm
Published: 2022-09-02 (Crawled : 18:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M |

Manufacturing

| -47.61% | O: 1.43% H: 0.0% C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -4.29% | O: -0.15% H: 0.29% C: -1.02%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -45.49% | O: 0.24% H: 0.13% C: -2.23%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 15.87% | O: 0.21% H: 0.86% C: -0.99%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -10.34% | O: 2.55% H: 0.0% C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 142.87% | O: 0.32% H: 0.04% C: -2.83%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 32.63% | O: 1.06% H: 1.35% C: -3.15%
treatment disease market ulcerative colitis

---

Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022
Published: 2022-05-18 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -20.9% | O: -0.72% H: 1.09% C: -9.3%
week disease

---

Parkinson's Disease (PD) Drugs market - 37% of Growth to Originate from Europe | Evolving Opportunities with AbbVie Inc. & Amneal Pharmaceuticals Inc. | Technavio
Published: 2022-05-18 (Crawled : 07:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 5.63% | O: -0.31% H: 0.53% C: -0.19%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -11.15% | O: -0.43% H: 0.0% C: 0.0%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -20.9% | O: -0.72% H: 1.09% C: -9.3%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 6.52% | O: -0.17% H: 0.59% C: -1.52%
ACAD | $16.82 -1.47% -1.49% 3.5M |

Health Technology

| 0.17% | O: -3.61% H: 1.39% C: -3.14%
europe disease growth market

---

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets, 2020-2021 & 2026
Published: 2022-04-25 (Crawled : 12:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K |

Health Technology

| -39.47% | O: -2.78% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -26.31% | O: -0.99% H: 0.0% C: -0.11%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -15.25% | O: 0.27% H: 0.0% C: 0.0%
MNKKQ | $0.02 |

Manufacturing

| -81.52% | O: -2.96% H: 2.29% C: -6.57%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -41.26% | O: -0.1% H: 0.35% C: -0.09%
VTRS | $11.25 1.17% 1.16% 4.7M |

Health Technology

| 4.12% | O: -5.01% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 2.91% | O: -0.67% H: 0.0% C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -20.61% | O: 0.01% H: 0.0% C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -12.45% | O: -1.57% H: 1.5% C: 1.39%
BSX | $67.33 -0.13% -0.31% 7M |

Health Technology

| 46.44% | O: -4.95% H: 2.32% C: 1.9%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -60.51% | O: -3.12% H: 0.37% C: 0.19%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 4.85% | O: -2.17% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -17.48% | O: -2.01% H: 0.0% C: 0.0%
NMRD | $0.0798 -28.78% 28K |

Health Technology

| -97.57% | O: 17.02% H: 0.52% C: -2.6%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 4.09% | O: -1.38% H: 0.65% C: 0.46%
device disease

---

Gastrointestinal Diseases Therapeutics Market to record USD 22.82 Bn growth | Evolving Opportunities with Abbott Laboratories and AbbVie Inc. | Technavio
Published: 2022-04-15 (Crawled : 11:00) - prnewswire.com
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| Email alert Add to watchlist
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| Email alert Add to watchlist
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510 |

Health Technology

| Email alert Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| Email alert Add to watchlist
AZNCF | $138.24 -4.19% 800 |

Health Technology

| Email alert Add to watchlist
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| Email alert Add to watchlist
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| Email alert Add to watchlist
gastrointestinal therapeutics growth market disease

---

New Report Reveals Barriers To Quality Care For Chronic Liver Disease Patients, A Cause Of Morbidity And Mortality Projected To Grow In The United States
Published: 2021-10-25 (Crawled : 12:00) - prnewswire.com
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -69.52% | O: 0.28% H: 1.95% C: 0.9%
disease liver disease liver

---

Bausch + Lomb Announces Statistically Significant Topline Results from the Second Phase 3 Trial Of NOV03 (perfluorohexyloctane) in Dry Eye Disease Associated with Meibomian Gland Dysfunction
Published: 2021-09-30 (Crawled : 12:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -68.94% | O: -0.39% H: 0.61% C: -0.64%
dry eye disease eye eye disease results topline phase 3 trial

---

Rise in Prevalence of Dry Eye Disease Due to Ageing, Use of Computers to Drive Dry Eye Disease Treatment Market, Says TMR
Published: 2021-08-23 (Crawled : 14:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -0.27% | O: 0.57% H: 0.42% C: -0.12%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -19.0% | O: -0.31% H: 0.3% C: -0.44%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -68.74% | O: 1.07% H: 0.6% C: -0.11%
dry eye disease treatment eye eye disease

---

Global Generic Drugs Market Report 2021: Market to Surpass $750 Billion by 2030 - Patent Expiration of Blockbuster Drugs & Growing Prevalence of Acute and Chronic Diseases
Published: 2021-06-04 (Crawled : 21:00) - prnewswire.com
ENDP | $0.2926 -9.6% |

Health Technology

| Email alert Add to watchlist
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| Email alert Add to watchlist
TEVA | $12.86 0.63% 0.0% 10M |

Health Technology

| Email alert Add to watchlist
TARO | $42.25 0.14% 0.0% 17K |

Health Technology

| Email alert Add to watchlist
PRGO | $30.8 2.87% -1.14% 1.2M |

Health Technology

| Email alert Add to watchlist
disease growing drug patent

---

Salix Will Feature New Data At Digestive Disease Week® 2021
Published: 2021-05-17 (Crawled : 12:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -69.93% | O: -0.14% H: 0.83% C: 0.76%
disease

---

Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction
Published: 2021-04-13 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -70.82% | O: 0.03% H: 0.17% C: -0.5%
dry eye disease eye eye disease results topline phase 3 trial

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---